Antibody and genetic testing in coeliac disease

Pathology

Volumn 35, Issue 4, 2003, Pages 285-304

  Wong, Richard C W ^a   Steele, Richard H ^b   Reeves, Glenn E M ^c   Wilson, Robert J ^a   Pink, Anne ^a   Adelstein, Stephen ^d  

^a QUEENSLAND HEALTH   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Antibody; Celiac disease syndrome; Coeliac disease syndrome; Diagnosis; Dietary compliance; Endomysial; Genetic; Gliadin; HLA DQ typing; IgA deficiency; Screening; Tissue transglutaminase

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN; HLA DQ ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN A DEFICIENCY; SCREENING;

EID: 0041832364     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020307527     Document Type: Article

References (177)

1. Gee S. On the coeliac affection. St Bartholomews Hosp Rep 1888; 24: 17-20.
2. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330-54.
3. Dicke WK. Investigation of the harmful effects of certain types of cereal on patients with coeliac disease [doctoral thesis]. Utercht: University of Utercht, The Netherlands, 1950.
4. Dicke WK, Weijers HA, van de Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 1952; 42: 34-42.
5. van de Kamer JH, Weijers HA, Dicke WK. Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 1953; 42: 223-31.
6. van de Kamer JH, Weijers HA, Dicke WK. Coeliac disease. V. Some experiments on the cause of the harmful effect of wheat gliadin. Acta Paediatr 1955; 44: 465-9.
7. Unsworth DJ. ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy. J Clin Pathol 1996; 49: 704-11.
8. Maki M, Collin P. Coeliac disease. Lancet 1997; 349: 1755-9.
9. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
10. Molberg O, McAdam SN, Körner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-7.
11. van de Wal Y, Kooy Y, van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-8.
12. Schuppan D, Dieterich W, Riecken EO. Exposing gliadin as a tasty food for lymphocytes. Nat Med 1998; 4: 666-7.
13. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53-81.
14. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-42.
15. Sollid LM. Coeliac disease: dissecting a complex inflammatory disease. Nat Rev Immunol 2002; 2: 647-55.
16. Seah PP, Fry L, Rossiter MA, Hoffbrand AV, Holborow EJ. Antireticulin antibodies in childhood coeliac disease. Lancet 1971; ii: 681-2.
17. Burgin-Wolff A, Hernandez R, Just M, Signer E. Immunofluorescent antibodies against gliadin: a screening test for coeliac disease. Helv Paediatr Acta 1976; 31: 375-80.
18. Chorzelski TP, Sulej J, Tchorzewska H, et al. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 1983; 420: 325-34.
19. Collin P, Hallstrom O, Maki M, Viander M, Keyrilainen O. Atypical coeliac disease found with serologic screening. Scand J Gastroenterol 1990; 25: 245-50.
20. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636-51.
21. Tighe MR, Hall MA, Barbado M, et al. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992; 40: 90-7.
22. Thorsby E, Lundin KE, Ronningen KS, Sollid LM, Vartdal F. Molecular basis and functional importance of some disease-associated HLA polymorphisms. Tissue Antigens 1989; 34: 39-49.
23. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997; 53: 1-11.
24. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11.
25. Murray JA. It's not time to put away the biopsy forceps. Am J Gastroenterol 1999; 94: 869-71.
26. Catassi C, Fabiani E, Ratsch IM, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr 1996; 412 (Suppl): 29-35.
27. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton L Jr. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol 1994; 89: 843-6.
28. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
29. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582-5.
30. Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999; 67: 257.
31. Hadjivassiliou M, Grunewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 2002; 72: 560-3.
32. Pellecchia MT, Scala R, Filla A, et al. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999; 66: 32-5.
33. Curione M, Barbato M, De Biase L, et al. Prevalence of coeliac disease in idiopathic dilated cardiomyopathy. Lancet 1999; 354: 222-3.
34. Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation 2002; 105: 2611-8.
35. Collin P, Vilska S, Heinonen PK, Hallstrom O, Pikkarainen P. Infertility and coeliac disease. Gut 1996; 39: 382-4.
36. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94.
37. Maki M, Holm K, Collin P, Savilahti E. Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut 1991; 32: 1412-4.
38. Kaukinen K, Collin P, Holm K, et al. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy. Scand J Gastroenterol 1998; 33: 944-9.
39. Collin P. New diagnostic findings in coeliac disease. Ann Med 1999; 31: 399-405.
40. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: 297-303.
41. Savilahti E, Simell O, Koskimies S, Rilva A, Akerblom HK. Celiac disease in insulin-dependent diabetes mellitus. J Pediatr 1986; 108: 690-3.
42. Collin P, Salmi J, Hallstrom O, et al. High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol 1989; 24: 81-4.
43. Sigurs N, Johansson C, Elfstrand PO, Viander M, Lanner A. Prevalence of coeliac disease in diabetic children and adolescents in Sweden. Acta Paediatr 1993; 82: 748-51.
44. Page SR, Lloyd CA, Hill PG, Peacock I, Holmes GK. The prevalence of coeliac disease in adult diabetes mellitus. Q J Med 1994; 87: 631-7.
45. De Vitis I, Ghirlanda G, Gasbarrini G. Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr 1996; 412 (Suppl): 56-7.
46. Talal AH, Murray JA, Goeken JA, Sivitz WI. Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol 1997; 92: 1280-4.
47. Not T, Tommasini A, Tonini G, et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001; 44: 151-5.
48. Iltanen S, Collin P, Korpela M, et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren's Syndrome. Am J Gastroenterol 1999; 94: 1042-6.
49. Cataldo F, Marino V, Bottaro G, Greco P, Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997; 131: 306-8.
50. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and 'Club del Tenue' Working Groups on Coeliac Disease. Gut 1998; 42: 362-5.
51. Lilic D, Sewell WA. IgA deficiency: what we should or should not be doing? J Clin Pathol 2001; 54: 337-8.
52. Collin P, Maki M, Keyrilainen O, et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367-71.
53. Dickey W, McMillan SA, McCrum EE, Evans AE. Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening. Eur J Gastroenterol Hepatol 1997; 9: 559-62.
54. Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology 1989; 97: 265-74.
55. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989; 30: 333-8.
56. Isaacson PG. Gastrointestinal lymphomas of T- and B-cell types. Mod Pathol 1999; 12: 151-8.
57. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. J Am Med Assoc 2002; 287: 1413-9.
58. Burgin-Wolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991; 66: 941-7.
59. Ferreira M, Davies SL, Butler M, et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33: 1633-7.
60. Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol 1994; 95: 78-82.
61. Lock RJ, Pitcher MCL, Unsworth DJ. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol 1999; 52: 274-7.
62. Bazzigaluppi E, Lampasona V, Barera G, et al. Comparison of tissue transglutaminase-specific antibody with established antibody measurements for coeliac disease. J Autoimmun 1999; 12: 51-6.
63. Hansson T, Dahlbom I, Hall J, et al. Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease. J Pediatr Gastroenterol Nutr 2000; 30: 379-84.
64. Wong RCW, Wilson RJ, Steele R, Radford-Smith G, Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002; 55: 488-94.
65. Grodzinsky E, Jansson G, Skogh T, Stenhammar L, Falth-Magnusson K. Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine. Acta Paediatr 1995; 84: 294-8.
66. Stiehm ER. Immunologic Disorders in Infants and Children. 4th ed. New York: WB Saunders Co., 1996: 268.
67. Unsworth DJ, Walker-Smith JA, Holborow EJ. Gliadin and reticulin antibodies in childhood coeliac disease. Lancet 1983; 1: 874-5.
68. Burgin-Wolff A, Berger R, Gaze H, et al. IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr 1989; 148: 496-502.
69. Juto P, Fredrikzon B, Hernell O. Gliadin-specific serum immunoglobulins A, E, G, and M in childhood: relation to small intestine mucosal morphology. J Pediatr Gastroenterol Nutr 1985; 4: 723-9.
70. Stahlberg MR, Savilahti E, Viander M. Antibodies to gliadin by ELISA as a screening test for childhood celiac disease. J Pediatr Gastroenterol Nutr 1986; 5: 726-9.
71. Martini S, Mengozzi G, Aimo G, et al. Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up. Clin Chem 2002; 48: 960-3.
72. Carroccio A, Vitale G, Di Prima L, et al. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 2002; 48: 1546-50.
73. Scott H, Brandtzaeg P. Endomysial Autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. 1st edn. Amsterdam: Elsevier, 1996: 237-44.
74. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-8.
75. Stern M. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr 2000; 31: 513-9.
76. Sugai E, Selvaggio G, Vazquez H, et al. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit. Am J Gastroenterol 2000; 95: 2318-22.
77. Dieterich W, Laag E, Schöpper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-21.
78. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8.
79. Brusco G, Izzi L, Corazza GR. Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol 1998; 30: 496-7.
80. Binder WL. New advances for serologic evaluation for celiac disease and dermatitis herpetiformis. Clin Immunol Newslett 1998; 18: 125-34.
81. Miller A, Paspaliaris W, Elliott PR, d'Apice A. Anti-transglutaminase antibodies and coeliac disease. Aust NZ J Med 1999; 29: 239-42.
82. Troncone R, Maurano F, Rossi M, et al. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 1999; 134: 166-71.
83. Biagi F, Ellis H, Yiannakou J, et al. Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol 1999; 94: 2187-92.
84. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45: 2142-9.
85. Amin M, Eckhardt T, Kapitza S, et al. Correlation between tissue transglutaminase antibodies and endomysium antibodies as diagnostic markers of coeliac disease. Clin Chim Acta 1999; 282: 219-25.
86. Seissler J, Borns S, Wohlrab U, et al. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 1999; 31: 375-9.
87. Williams AJ, Annis P, Lock RJ, et al. Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase. J Immunol Methods 1999; 228: 81-5.
88. Reeves GEM, Burns C, Hall ST, et al. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods. Pathology 2000; 32: 181-5.
89. Gillett HR, Freeman HJ. Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease. Can J Gastroenterol 2000; 14: 668-71.
90. Clemente MG, Musu MP, Frau F, et al. Immune reaction against the cytoskeleton in coeliac disease. Gut 2000; 47: 520-6.
91. Sblattero D, Berti I, Trevisiol C, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95: 1253-7.
92. Koop I, Ilchmann R, Izzi L, et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000; 95: 2009-14.
93. Sardy M, Karpati S, Peterfy F, et al. Comparison of a tissue transglutaminase ELISA with the endomysium antibody test in the diagnosis of gluten-sensitive enteropathy. Z Gastroenterol 2000; 38: 357-64.
94. Baldas V, Tommasini A, Trevisiol C, et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000; 47: 628-31.
95. Chan A, Butzner J, McKenna R, Fritzler M. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Paediatrics 2001; 107: E8 (abstract).
96. Leon F, R-Pena R, Camerero C, et al. Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology 2001; 120: 586-7.
97. Basso D, Gallo N, Guariso G, et al. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal 2001; 15: 112-5.
98. Jaskowski TD, Schroder C, Martins TB, Litwin CM, Hill HR. IgA antibodies against endomysium and transglutaminase: A comparison of methods. J Clin Lab Anal 2001; 15: 108-11.
99. Dahele A, Kingstone K, Bode J, Anderson D, Ghosh S. Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig Dis Sci 2001; 46: 214-21.
100. Dahele AV, Aldhous MC, Humphreys K, Ghosh S. Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. Q J Med 2001; 94: 195-205.
101. Dickey W, McMillan SA, Hughes DF. Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease. Scand J Gastroenterol 2001; 36: 511-4.
102. Bonamico M, Tiberti C, Picarelli A, et al. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am J Gastroenterol 2001; 96: 1536-40.
103. Salmaso C, Ocmant A, Pesce G, et al. Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease. Allergy 2001; 56: 544-7.
104. Fabiani E, Catassi C. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol 2001; 13: 659-65.
105. Leon F, Camarero C, R-Pena R, et al. Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol 2001; 36: 849-53.
106. Martini S, Mengozzi G, Aimo G, Pagni R, Sategna-Guidetti C. Diagnostic accuracies for celiac disease of four tissue transglutaminase autoantibody tests using human antigen. Clin Chem 2001; 49: 1722-5.
107. Chorzelski TP, Beutner EH, Sulej J, et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984; 111: 395-402.
108. Lasagni D, Ferrari R, Lapini M. Unmasking anti-endomysial antibodies in coeliac subjects positive for anti-smooth muscle antibodies. Acta Paediatr 1999; 88: 462-4.
109. ISO/IEC 17025 Application Document. Version 1 (Section 5.9), 2000:20.
110. Russo PA, Chartrand LJ, Seidman E. Comparative analysis of serologic screening tests for the initial diagnosis of celiac disease. Pediatrics 1999; 104: 75-8.
111. Unsworth DJ. Reticulin autoantibodies. In: Peter JB, Shoenfeld Y, editors. Autoantibodies. 1st edn. Amsterdam: Elsevier, 1996: 684-93.
112. Rizzetto M, Doniach D. Types of 'reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol 1973; 26: 841-51.
113. Lock RJ, Gilmour JEM, Unsworth DJ. Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease. Clin Exp Immunol 1999; 116: 258-62.
114. Brusco G, Muzi P, Ciccocioppo R, et al. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Clin Exp Immunol 1999; 118: 371-5.
115. Uhlig HH, Lichtenfeld L, Osman AA, Richter T, Mothes T. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 2000; 12: 1017-20.
116. Sorell L, Garrote JA, Acevedo B, Arranz E. One-step immunochromatographic assay for screening of coeliac disease. Lancet 2002; 359: 945-6.
117. Kumar PJ, Ferguson A, Lancaster-Smith M, Clark ML. Food antibodies in patients with dermatitis herpetiformis and adult coeliac disease - relationship to jejunal morphology. Scand J Gastroenterol 1976; 11: 5-9.
118. Casadio R, Polverini E, Mariani P, et al. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem 1999; 262: 672-9.
119. Nakachi K, Swift G, Wilmot D, et al. Antibodies to tissue transglutaminase: comparison of ELISA and immunoprecipitation assay in the presence and in the absence of calcium ions. Clin Chim Acta 2001; 304: 75-84.
120. Empson MB. Statistics in pathology laboratory: diagnostic test interpretation. Pathology 2002; 34: 365-9.
121. Cataldo F, Lio D, Marino V, et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 2000; 47: 366-9.
122. Picarelli A, Tola MD, Sabbatella L, et al. Identification of a new coeliac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency. J Intern Med 2001; 249: 181-8.
123. Troncone R, Mayer M, Spagnolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 1995; 21: 69-72.
124. Bardella MT, Trovato C, Cesana BM, et al. Serological markers for coeliac disease: is it time to change? Dig Liver Dis 2001; 33: 426-31.
125. Kilander AF, Nilsson LA, Gillberg R. Serum antibodies to gliadin in coeliac disease after gluten withdrawal. Scand J Gastroenterol 1987; 22: 29-34.
126. Burgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002; 37: 685-91.
127. Ciacci C, Cavallaro R, della Valle N, d'Argenio G. The use of serum tTG-ab assay in patients on gluten-free diet as a measure of dietetic compliance. Gastroenterology 2002; 122: 588.
128. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000; 95: 712-4.
129. Maki M, Sulkanen S, Collin P. Antibodies in relation to gluten intake. Dig Dis 1998; 16: 330-2.
130. Kaukinen K, Sulkanen S, Maki M, Collin P. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002; 14: 311-5.
131. McMillan SA, Dickey W, Douglas JP, Hughes DF. Transthyretin values correlate with mucosal recovery in patients with coeliac disease taking a gluten free diet. J Clin Pathol 2001; 54: 783-6.
132. Reifen R, Reif S, Buskila D, Berkovitz Z, Lerner A. Transthyretin: a marker for celiac disease activity. J Med 1998; 29: 30-6.
133. Cataldo F, Ventura A, Lazzari R, et al. Antiendomysium antibodies and coeliac disease: solved and unsolved questions. An Italian multicentre study. Acta Paediatr 1995; 84: 1125-31.
134. da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, et al. Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci 2001; 46: 2624-30.
135. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002; 50: 624-8.
136. Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha EG. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum Immunol 1995; 42: 295-300.
137. McManus R, Moloney M, Borten M, et al. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum Immunol 1996; 45: 24-31.
138. Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002; 97: 695-9.
139. Hall MA, Lanchbury JS, Lee JS, Welsh KI, Ciclitira PJ. HLA-DQ2 second-domain polymorphisms may explain increased transassociated risk in celiac disease and dermatitis herpetiformis. Hum Immunol 1993; 38: 284-92.
140. Tissue Typing Dynal - SSP. Technical Handbook. 1st edn. Oslo: Dynal, 1996: 49-51.
141. Trachtenberg EA, Keyeux G, Bernal J, Noble JA, Erlich HA. Results of Expedicion Humana. II. Analysis of HLA class II alleles in three African American populations from Colombia using the PCR/SSOP: identification of a novel DQB1*02 (*0203) allele. Tissue Antigens 1996; 48: 192-8.
142. Olerup O, Aldener-Cannava A, Fogdell-Hahn A, et al. DQB1*0202 and the new DQB1*0203 allele: a fourth pair of DQB1 alleles differing only at codon 57. Tissue Antigens 1997; 49: 271-3.
143. Stern M, Bender SW, Gruttner R, Posselt HG, Strobel S. Serum antibodies against gliadin and reticulin in a family study of coeliac disease. Eur J Pediatr 1980; 135: 31-6.
144. Maki M, Holm K, Lipsanen V, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet 1991; 338: 1350-3.
145. Farre C, Humbert P, Vilar P, et al. Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig Dis Sci 1999; 44: 2344-9.
146. Shanahan F, McKenna R, McCarthy CF, Drury MI. Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med 1982; 51: 329-35.
147. Lampasona V, Bazzigaluppi E, Barera G, Bonifacia E. Tissue transglutaminase and combined screening for coeliac disease and type 1 diabetes-associated autoantibodies. Lancet 1998; 352: 1192-3.
148. Barera G, Bianchi C, Calisti L, et al. Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child 1991; 66: 491-4.
149. George EK, Mearin ML, Bouquet J, et al. High frequency of celiac disease in Down syndrome. J Pediatr 1996; 128: 555-7.
150. Gale L, Wimalaratna H, Brotodiharjo A, Duggan JM. Down's syndrome is strongly associated with coeliac disease. Gut 1997; 40: 492-6.
151. Csizmadia CG, Mearin ML, Oren A, et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr 2000; 137: 756-61.
152. Book L, Hart A, Black J, et al. Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet 2001; 98: 70-4.
153. Ivarsson SA, Carlsson A, Bredberg A, et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr 1999; 88: 933-6.
154. Rujner J, Wisniewski A, Gregorek H, et al. Coeliac disease and HLA-DQ 2 (DQA1* 0501 and DQB1* 0201) in patients with Turner syndrome. J Pediatr Gastroenterol Nutr 2001; 32: 114-5.
155. Doganci T, Caliskan L, Vidinlisan S. Celiac disease and HLA-DQ2 association in patients with Turner syndrome. J Pediatr Gastroenterol Nutr 2001; 33: 352.
156. Hadjivassiliou M, Grunewald RA, Lawden M, et al. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001; 56: 385-8.
157. Pellecchia MT, Scala R, Perretti A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology 1999; 53: 1606-8.
158. Maki M, Holm K, Koskimies S, Hallstrom O, Visakorpi JK. Normal small bowel biopsy followed by coeliac disease. Arch Dis Child 1990; 65: 1137-41.
159. Maki M, Huupponen T, Holm K, Hallstrom O. Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. Gut 1995; 36: 239-42.
160. Koletzko S, Burgin-Wolff A, Koletzko B, et al. Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr 1988; 148: 113-7.
161. Lorini R, Scotta MS, Cortona L, et al. Celiac disease and type I (insulin-dependent) diabetes mellitus in childhood: follow-up study. J Diabetes Complications 1996; 10: 154-9.
162. Collin P, Helin H, Maki M, Hallstrom O, Karvonen AL. Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. Scand J Gastroenterol 1993; 28: 595-8.
163. Vazquez H, Cabanne A, Sugai E, et al. Serological markers identify histologically latent coeliac disease among first-degree relatives. Eur J Gastroenterol Hepatol 1996; 8: 15-21.
164. Johnston SD, Watson RG, McMillan SA, Evans AE, Love AH. Serological markers for coeliac disease: changes with time and relationship to enteropathy. Eur J Gastroenterol Hepatol 1998; 10: 259-64.
165. Scott BB, Losowsky MS. Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. Gut 1976; 17: 984-92.
166. Kordonouri O, Dieterich W, Schuppan D, et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med 2000; 17: 441-4.
167. Chirdo FG, Rumbo M, Carabajal P, et al. Determination of anti-omega-gliadin antibodies in serologic tests for coeliac disease. Scand J Gastroenterol 2000; 35: 508-16.
168. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000; 35: 181-3.
169. Not T, Citta A, Lucchesi A, et al. Anti-endomysium antibody on human umbilical cord vein tissue: an inexpensive and sensitive diagnostic tool for the screening of coeliac disease. Eur J Pediatr 1997; 156: 616-8.
170. Rostami K, Kerckhaert J, von Blomberg BM, et al. SAT and serology in adult coeliacs, seronegative coeliac disease seems a reality. Neth J Med 1998; 53: 15-9.
171. Kaukinen K, Maki M, Partanen J, Sievanen H, Collin P. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001; 46: 879-87.
172. Berger R, Schmidt G. Evaluation of six anti-gliadin antibody assays. J Immunol Methods 1996; 191: 77-86.
173. Kumar V, Jarzabek-Chorzelska M, Sulej J, Rajadhyaksha M, Jablonska S. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis. Clin Immunol 2001; 98: 378-82.
174. de Lecea A, Ribes-Koninckx C, Polanco I, Calvete JF. Serological screening (antigliadin and antiendomysium antibodies) for non-overt coeliac disease in children of short stature. Acta Paediatr 1996; 412 (Suppl): 54-5.
175. Grodzinsky E. Screening for coeliac disease in apparently healthy blood donors. Acta Paediatr 1996; 412 (Suppl): 36-8.
176. Hakeem V, Fifield R, al-Bayaty HF, et al. Salivary IgA antigliadin antibody as a marker for coeliac disease. Arch Dis Child 1992; 67: 724-7.
177. Kelly J, O'Farrelly C, Rees JP, Feighery C, Weir DG. Humoral response to alpha gliadin as serological screening test for coeliac disease. Arch Dis Child 1987; 62: 469-73.